Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Researchers attribute lack of Alzheimer’s treatment to prior misguidedness efforts

Staff Writer
Staff Writer 1 year ago
Updated 2022/01/22 at 2:36 AM
Share
SHARE

Amid many years of research aimed at understanding the progression of neurodegenerative diseases, like Alzheimer’s disease, no cure or treatment exists.

In the Journal of Molecular Neuroscience, researchers associated with Carnegie Mellon University determined through their new data that past efforts to establish an effective treatment for Alzheimer’s has been set up for failure because of misguidedness.

“Based on our findings, Alzheimer’s requires a similar approach to HIV treatment, where you have a cocktail of drugs used to address different elements of the disease,” said one author of the study.

“Together, these drugs work toward the larger goal; treating the symptoms of Alzheimer’s in a particular patient.”


According to author Liqing Song and colleagues: “Our study shows that monomeric tau is rapidly endocytosed by multiple CNS-relevant cell lines, and the fastest tau endocytosis rate was observed in glial cells among all the cell types tested.”

“This study demonstrates the important role of both HSPGs and LRP1 in regulating cellular immune responses to tau protein monomers, providing a novel target for alleviating the neuroinflammatory environment before the formation of neurofibrillary tangles.”

You Might Also Like

New study explores test that can detect Alzheimer’s years before diagnosis

New research explores the association between viral infection and Alzheimer’s disease

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

New research finds Alzheimer’s risk factors affect males and females very differently

TAGGED: Alzheimer's disease, cognition
Staff Writer January 21, 2022
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Feeding problems may serve as an indicator of developmental delay in early childhood
Next Article New Zealand study unveils children are exposed to at least one brand per minute

Recommended

Clinical

New study explores test that can detect Alzheimer’s years before diagnosis

1 Min Read
Health

New research explores the association between viral infection and Alzheimer’s disease

1 Min Read
Clinical

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

1 Min Read
Clinical

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?